🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- G1110E107
- Market Cap
- Mid Cap · $859 Million
- IPO
- 10/21/2022 · $10.50/share
Business: Biohaven Ltd. is a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies for people with debilitating neurological and neuropsychiatric diseases, including rare disorders.
Company Contact
- CEO
- Vlad Coric
- CFO
- Matthew Buten
- Headquarters
- 215 Church Street,New Haven, CT 06510
- Phone
- 203-404-0410
- Investor Relations
- Jennifer Porcelli · 203-404-0410 · jennifer.porcelli@biohavenpharma.com